Modified Corona Score can easily identify Covid-19 patients with gastrointestinal symptoms: an Italian proposal
Gastroenterology and Hepatology from Bed to Bench,
Vol. 13 No. 4 (2020),
20 September 2020
,
Page 393-395
https://doi.org/10.22037/ghfbb.v13i4.2039
Abstract
Diarrhea is common after liver transplant. Although the majority of episodes are experienced during the first year of transplantation, they can occur any time after the procedure. Diarrhea can impose a major risk of morbidity and mortality on transplanted patients; so a careful evaluation is required to manage it. There are few studies highlighting the gastrointestinal manifestations of COVID-19, in particular among immunosuppressed patients. The predominant respiratory symptoms of coronavirus cause GI aspects of the virus to be overlooked. This study represents a young woman with a history of liver transplant who was referred to the hospital because of diarrhea, fever, and abdominal pain attributed to coronavirus infection.
Keywords: COVID-19, liver transplant, Diarrhea.
(Please cite as: Hatami B, Ketabi Moghadam P, Zali MR. Presentation of COVID-19 in a liver transplant recipient. Gastroenterol Hepatol Bed Bench 2020;13(4):396-399).
- Modified Corona Score, Covid-19, RT-PCR, Gastrointestinal onset, laboratory parameters
How to Cite
References
Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology. 1994;107:1398-1407.
Altiparmak MR, Trablus S, Pamuk ON, Apaydin S, Sariyar M, Ozturk R, et al. Diarrhea following renal transplantation. ClinTransplant. 2002;16:212-216.
Wong NA, Bathgate AJ, Bellamy CO. Colorectal disease Eur J Gastroenterol Hepatol. 2002;14:231-236.
Willingham FF, Ticona CE, Taylor DN, Bowen AB, Crane AR, Gottlieb AL, et al. Diarrhea and Clostridium difficile infection in Latin American patients with AIDS. Working Group on AIDS in Peru. Clin Infect Dis. 1998;27:487-493.
Philip M. Ginsburg and Paul J. Thuluvath. Diarrhea in Liver Transplant Recipients: Etiology and Management. Liver Transpl. 2005;11(8):881-890.
Alexander JA, Cuellar RE, Fadden RJ, Genovese JJ, Gavaler JS,Van Thiel DH. Cytomegalovirus infection of the upper gastrointestinal tract before and after liver transplantation. Transplantation. 1988;46:378-382.
Van Thiel DH, Gavaler JS, Schade RR, Chien MC, Starzl TE. Cytomegalovirus infection and gastric emptying. Transplantation. 1992;54:70-73.
Palau LA, Kemmerly SA. First report of invasive amebiasis in an organ transplant recipient. Transplantation. 1997;64:936-937.
Mack DR, Dhawan A, Kaufman SS, Langnas AN, Seemayer TA. Small bowel bacterial overgrowth as a cause of chronic diarrhea after liver transplantation in children. Liver Transpl Surg. 1998;4:166-169
Maes BD, Dalle I, Geboes K, Oellerich M, Armstrong VW, Evenepoel P, et al. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation. 2003;75:665-672.
Maes BD, Lemahieu W, Kuypers D, Evenepoel P, Coosemans W, Pirenne J, et al. Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. Am J Transplant. 2002;2:989-992.
Teisseyre J, Teisseyre M, Kalicinski P, Ismail H, Drewniak T, Kaminski A, et al. Elevated tacrolimus levels during diarrhea in children after liver transplantation. Transplant Proc. 2003;35:2292-2294.
Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, et al. Liver transplant-associated graft-versus-host disease. Transplantation. 2003;75:118-126.
Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002;236:429-436
Dvorchik I, Subotin M, Demetris AJ, Fung JJ, Starzl TE, Wie S, et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology. 2002;35:380-384.
Atassi T, Thuluvath PJ. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy. J Clin Gastroenterol. 2003;37:72-73.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766-73.
Tian Y, Rong L, Nian W, He Y. gastrointestinal features in COVID‐19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843-51.
Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002-9.
Tian Y, Rong L, Nian W, He Y. gastrointestinal features in COVID‐19 and the possibility of fecal transmission. Aliment Pharmacol Ther. 2020;51(9):843-51.
Charles J. Kahi. Gastrointestinal aspects of COVID-19 reviewing NEJM 2020 Cheung KS et al. Gastroenterology. 2020 Apr 3; [e-pub].
Romanelli A, Mascolo S. Immunosuppression drug‐related and clinical manifestation of Coronavirus disease 2019: a therapeutical hypothesis. Am J Transplant. 2020; [Epub ahead of print].
- Abstract Viewed: 21 times
- PDF Downloaded: 21 times